ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,327Medicare Part D Prescriptions Filled, Including Refills

Rank: 160 out of 780

$926K Total Retail Price of All Prescriptions

Rank: 81 out of 780

550 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

35% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 7,924 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 902 390 S3 1 1
OMEPRAZOLE 466 264 2 3
SIMVASTATIN 463 275 3 2
FUROSEMIDE 402 265 4 7
AMLODIPINE BESYLATE 263 189 5 4
LISINOPRIL 251 146 6 6
ZOLPIDEM TARTRATE 230 154 7 17
ATORVASTATIN CALCIUM 223 148 8 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 222 101 9 26
LEVOTHYROXINE SODIUM 211 154 10 5
MELOXICAM 200 139 11 16
CLOPIDOGREL 200 127 11 34
GABAPENTIN 195 120 13 13
PRAVASTATIN SODIUM 194 157 14 9
METFORMIN HCL 185 124 15 8
LYRICA 182 74 16 52
PANTOPRAZOLE SODIUM 182 96 16 25
POTASSIUM CHLORIDE 173 110 18 11
CARVEDILOL 167 98 19 14
PROMETHAZINE HCL 156 40 R 20 66
CITALOPRAM HBR 153 117 21 23
NEXIUM 137 69 22 22
PLAVIX 132 88 23 45
TRAMADOL HCL 132 76 23 15
LOSARTAN-HYDROCHLOROTHIAZIDE 131 103 25 33
AZITHROMYCIN 131 63 25 38
CRESTOR 127 63 27 32
CYCLOBENZAPRINE HCL 125 51 R 28 42
METOPROLOL SUCCINATE 121 94 29 20
GLYBURIDE-METFORMIN HCL 121 76 R 29 108
TIZANIDINE HCL 119 51 31 82
OXYCODONE HCL 118 47 S2 32 123
PROAIR HFA 111 34 33 62
KLOR-CON M20 108 81 34 57
ISOSORBIDE MONONITRATE ER 108 75 34 60
DONEPEZIL HCL 100 98 36 31
TAMSULOSIN HCL 98 63 37 36
MIRTAZAPINE 93 78 38 58
GLIMEPIRIDE 92 52 39 30
FLUTICASONE PROPIONATE 84 51 40 41
SPIRIVA 84 40 40 72
ROPINIROLE HCL 78 26 42 87
LANTUS 77 26 43 71
PREDNISONE 77 56 43 40
TRIAMTERENE-HCTZ 72 49 45 37
WARFARIN SODIUM 70 40 46 24
CARISOPRODOL 70 0 R 46 67
ADVAIR DISKUS 68 28 48 68
PEN NEEDLE 67 18 49 136
PAROXETINE HCL 66 19 50 69
METOPROLOL TARTRATE 65 39 51 19
OXYCONTIN 65 44 S2 51 165
CLONIDINE HCL 64 45 53 28
CYMBALTA 62 14 54 51
ESCITALOPRAM OXALATE 62 33 54 61
IBUPROFEN 60 20 56 93
COLCRYS 60 33 56 131
LOSARTAN POTASSIUM 60 36 56 18
FAMOTIDINE 60 44 56 86
METFORMIN HCL ER 59 41 60 43
SPIRONOLACTONE 58 17 61 53
OXYCODONE HCL-ACETAMINOPHEN 58 18 S2 61 146
INSULIN SYRINGE 57 23 63 80
ALENDRONATE SODIUM 57 50 63 44
ACTOS 56 44 65 144
MECLIZINE HCL 55 41 66 83
ALLOPURINOL 55 40 66 29
CIPROFLOXACIN HCL 55 35 66 49
DICLOFENAC SODIUM 54 34 69 137
ENDOCET 52 24 S2 70 129
AMLODIPINE BESYLATE-BENAZEPRIL 51 36 71 50
VERAPAMIL ER 50 29 72 78
NAMENDA 50 49 72 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.